Which critical medicines are in short supply in the EU?
ADVERTISEMENT
The European Union is in short supply of 16 medicines that are considered 'critical' for people's health.
A drug can be put on the EU's shortages list because of production issues, a surge in demand, or a drugmaker deciding to pull it off the market – anything that limits the bloc's supply on either a temporary or permanent basis.
There are ongoing shortages of 34 medicines, according to the European Medicines Agency (EMA). Sixteen of those are on the EU's list of essential drugs that the European Commission aims to bolster through its new Critical Medicines Act.
Here are the critical medicines in short supply in the EU, according to the latest available information from the EMA and member states.
Cyanide poisoning antidote
Cyanokit is the only EU-approved medicine to treat cyanide poisoning. It contains the active ingredient hydroxocobalamin or vitamin B12a, which is on the EU's critical medicines list.
In December 2024, health authorities said Cyanokit manufacturing was being suspended after the drugmaker discovered that some batches may have been contaminated. However, because the risk of contamination is low and there is no alternative antidote, they are still in circulation, according to the EMA. The shortage is expected to be resolved by May 2025.
Amoxicillin
Amoxicillin is an antibiotic for bacterial infections. Shortages began in October 2022 after an uptick in respiratory illnesses led to higher demand for antibiotics.
Related Big pharma urges Commission to slow down on new critical medicines rules
Manufacturers also lacked enough staff to make the medicine, the EMA said. These issues have since eased in most countries, but some intermittent supply problems persist across Europe.
Some inhalers
People with asthma, chronic obstructive pulmonary disease (COPD), and other breathing issues take salbutamol, typically using an inhaler or a nebuliser.
Manufacturers are struggling to meet the growing demand for inhalers, leading to intermittent shortages of salbutamol across most of the EU. Alternatives are available, but the scarcity is expected to last until at least mid-2025.
A few types of insulin
Patients with type 1 or 2 diabetes take insulin to control their blood sugar. Manufacturing problems for certain types of insulin – Insuman Rapid, Basal and Comb 25 – in early 2023, caused delays across the supply chain.
The drugmaker also decided to stop producing these types of insulin, prompting the EMA to urge doctors to transition their patients to other brands.
Seven cancer drugs
The EU does not have enough of seven drugs used to treat various types of cancers, including hycamtin, methotrexate, fludarabine, fluorouracil, cisplatin, fasturtec, and paclitaxel.
The shortages are mainly due to manufacturing problems, though unexpected demand for methotrexate injections – which can also help treat inflammatory conditions like rheumatoid arthritis, psoriasis, and Crohn's disease – has exacerbated their scarcity in some European countries.
Shortages are beginning to be resolved for several of these medications, and in the meantime, alternative options are available for some of them.
ADVERTISEMENT
Vaccine for mosquito-borne virus
Ixiaro is a vaccine for Japanese encephalitis, which is related to the dengue, yellow fever, and West Nile viruses and causes brain inflammation. Increased demand and manufacturing problems caused a shortage of the vaccine, though supply levels have since improved.
The EMA expected the shortage, which has affected Ireland, Italy, Poland, Portugal, and Spain, to be resolved by late January, but Irish authorities now say it should be back in stock there by the end of April 2025.
Blood disease medicine
Peginterferon alfa-2a, sold as Pegasys, is used to treat chronic hepatitis B and C as well as other blood diseases.
Unexpectedly high demand for the medicine has led to shortages that the EMA said should be resolved later in 2025.
ADVERTISEMENT
Schizophrenia treatment
Zypadhera, also known as olanzapine, helps treat schizophrenia.
Patients who have taken the drug by mouth can then start taking it via injection – but the needles are in short supply due to manufacturing issues, leading to intermittent shortages of Zypadhera in some European countries. Limited quantities are now available in places like Belgium.
Heart attack prevention drug
Integrilin can help prevent heart attacks for adults with severe chest pain and those who have already had a certain type of heart attack.
Supply issues with the active ingredient, eptifibatide, prompted drugmaker GlaxoSmithKline to stop manufacturing the medicine and pull it off the EU market. However, alternatives are available.
ADVERTISEMENT
Eye problems medicine
Verteporfin, sold as Visudyne, is a treatment for people with certain eye problems, for example a type of age-related macular degeneration.
Manufacturing has been limited since May 2020, leaving the medicine in short supply, though other treatments are available. Limited quantities are now available in places like Austria, with a restock there expected by the end of 2025.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Euronews
a day ago
- Euronews
What's driving the rise in STIs among older Europeans?
Sexually transmitted infections (STIs) are not exclusively a problem of young people. Young adults in their 20s and 30s usually top the charts for common bacterial STIs such as gonorrhoea, chlamydia, and syphilis – but rates among those in midlife and beyond are climbing in parts of Europe. According to a 2024 report from the United Kingdom's Health Security Agency, there has been a 'steady increase' in STI diagnoses among people aged 65 years and older in recent years. There were 1,649 gonorrhoea, chlamydia, and syphilis diagnoses among older Britons in 2023, up from 576 in 2014 – a nearly threefold increase. In France, meanwhile, gonorrhoea and syphilis incidence rose more sharply in people over 50 than in younger adults between 2021 and 2023. Chlamydia also rose among men over 50, according to the French public health agency. In Denmark, men aged 50 and above saw some of the largest increases in gonorrhea cases from 2022 to 2023. And across the European Union, people aged 45 and older accounted for 32 per cent of all syphilis cases in 2023. Infections like gonorrhoea, chlamydia, and syphilis are bacterial STIs which can be cured with antibiotics, unlike herpes and HIV, which are lifelong viral infections, according to the World Health Organization (WHO). Why are STI cases rising among older adults? The uptick does not appear to be slowing down. According to a study from the University of Manchester in the UK, the number of STI diagnoses is expected to continue rising among older people in England through at least 2040. The study authors said it is not clear what's driving this trend, but that the ageing population and growing number of diagnoses could translate to rising treatment costs for STIs in the coming years. Other experts say that because women often outlive men, they may look for new partners later in life. Meanwhile, sexual performance drugs such as Viagra have given some older men a chance to re-engage in sex later in life. Older adults may also have little knowledge about how different types of STIs are transmitted or how to prevent them from spreading, particularly given they are safe from the risk of unintended pregnancies, one small study concluded. Destigmatising STIs in older adults Experts say both health care professionals and the public should consider the sexual health needs of older people. 'There is a common misconception that older adults do not have sex, they don't want to have sex, or they cannot have sex,' said Matthew Smith, a Texas A&M professor focused on older adults' health at Texas A&M University in the United States. 'And unfortunately, those misconceptions can lead to a lack of communication, a lack of speaking with health care providers, a lack of talking to partners about safer sex practices like using condoms or sharing partners,' he added. Whether they are widowed, divorced, or simply seeking companionship, Smith said older adults should ask potential new partners about their sexual history, use of contraception, and STI testing – topics he said are 'not necessarily something routine among older adults'. Smith said doctors should also discuss sexual health with their patients, given 'we are sexual beings across the life course'. 'It's something that oftentimes is shied away from, in conversation,' he said. 'There's a little bit of stigma based on [their] age, where not everybody likes to envision that age group engaging in these behaviours'.
Euronews
2 days ago
- Euronews
Want to keep your brain sharp in old age? Helping others could be key
'What goes around comes around' may be just an expression, but helping others could have significant benefits for our brains as we age, a new study has found. Middle-aged and older adults who regularly help people they do not live with experience considerably slower cognitive decline than those who do not help others, according to the study, which was published in the journal Social Science and Medicine. Researchers analysed data from more than 30,000 adults aged 51 or older in the United States whose brain health was tracked from 1998 to 2020. Scientists explored how both formal helping, such as volunteering in an organisation, and informal helping, like assisting a neighbour or a friend outside the house, affect cognitive wellbeing and health over time. The study found that both formal and informal helping were associated with higher levels of cognitive function and a slower cognitive decline later in life, whereas withdrawing from these activities was linked to poorer cognitive ability. 'Informal helping is sometimes assumed to offer fewer health benefits due to its lack of social recognition,' Sae Hwang Han, an assistant professor of human development and family sciences at the University of Texas and one of the study's authors, said in a statement. 'It was a pleasant surprise to find that it provides cognitive benefits comparable to formal volunteering,' he added. According to the study, older adults did not need to commit much time to helping others to see the cognitive benefits. Even moderate engagement of two to four hours per week was linked to substantial advantages for brain health. 'The cognitive benefits of helping others weren't just short-term boosts but cumulative over time with sustained engagement,' Han said. However, the study also has some limitations. It did not provide details on the exact ways that people volunteered, relied on self-reported data, and cannot claim with certainty a cause-and-effect relationship between volunteering and brain health. Even so, the results are in line with previous findings. Earlier research has suggested a positive link between cognitive performance and volunteering, with some studies even highlighting that the benefits are particularly significant for women. Notably, however, volunteering opportunities often target young people. In the European Union, official regional programmes like the European Solidarity Corps are open to those aged 18 to 30 to contribute to social projects across the bloc. No such programme exists for middle-aged and older adults. In 2021, the European Commission recommended that older adults volunteer in its Green Paper on Ageing, but the focus was on intergenerational cooperation and enhanced self-esteem, not cognitive health. Han said the latest findings suggest older adults should stay active members of their communities as long as possible, for their own sake as much as others'. 'This suggests the importance of keeping older adults engaged in some form of helping for as long as possible, with appropriate supports and accommodations in place,' he said.
Euronews
2 days ago
- Euronews
How many tropical nights have occurred across Europe?
Europe saw the second-highest number of tropical nights on record in 2024 due to climate change, according to the EU's Copernicus service (C3S). A tropical night is defined as a night when the temperature does not drop below 20C. Over the past few decades, the number of tropical nights in Europe has been rising. The rate of warming is more than double the global average over the last 30 years. The southeast of Europe was particularly affected, with some areas of southern Greece experiencing up to 55 more tropical nights than average. Much of Italy saw up to 50 additional tropical nights, while western Turkey recorded up to 40 more. Some regions in Croatia, Serbia, Hungary, Romania, and Bulgaria experienced up to 35 extra tropical nights. In June and early July of 2025, many areas across the European continent experienced more tropical nights than usual for that period. Parts of Spain, for example, recorded up to 24 tropical nights in June, which is 18 more than the average for that month. Linked to the marine heatwave in the Mediterranean Sea, coastal areas around the Mediterranean Sea saw around 10 to 15 tropical nights, despite typically not experiencing any in June. A World Weather Attribution study has also found that Sweden endured 10 consecutive tropical nights due to a prolonged Nordic heatwave. "Nighttime temperatures have been made about 2C hotter than they would have been without human-caused climate change, and around 33 times more likely," the report stated. "After a further 1.3C of warming, nighttime temperatures are projected to warm by a further 1.7C, with temperatures like those recorded in 2025 a further seven times more likely to occur. " How do tropical nights affect your health? Tropical nights might mean a sleepless, sweaty time in bed, when bed sheets cling to skin and opening windows brings no respite. Besides being uncomfortable, high nighttime temperatures can pose health risks, as the body may not recover from daytime heat stress as it normally would. Symptoms of heat stress include increased heart rate, dizziness, and, in severe cases, heat stroke. There were estimated to be around 47,700 heat-related deaths in Europe in 2023, and around 61,700 in 2022.
